AI for imaging at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
11 organizations at BioTechX Europe 2026 present work in AI for imaging: 4 academic, government and non-profit bodies, 4 technology and service providers and 3 drug developers. Between them they bring 55 presentations to the program. Most represented: Roche (39 on the program), Servier (4 on the program), Sanofi (4 on the program). 9 of them have their own page in this guide. As of Sep 26, 2026.
Format
Top represented
Showing 1–4 of 11 organizations
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
Roche Basel, Switzerland | |
Swiss healthcare company developing pharmaceuticals and diagnostics. | Chair Tue Oct 6 11:40 Talk Tue Oct 6 12:05 Talk Tue Oct 6 12:25 Talk Tue Oct 6 13:05 Talk Tue Oct 6 13:05 Chair Tue Oct 6 15:25 Talk Tue Oct 6 15:30 Talk Tue Oct 6 15:50 Data Management in the era of AI - What it takes to deliver value at scale Why AI assistants give wrong answers from correct company data, and how to supply the context people once filled in themselves. Talk Tue Oct 6 15:50 Panel Tue Oct 6 16:10 Talk Tue Oct 6 16:30 Talk Tue Oct 6 16:30 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Panel Tue Oct 6 17:25 Talk Wed Oct 7 12:05 Talk Wed Oct 7 12:25 Building Responsible AI: Lessons for Life Sciences How life sciences companies can manage the risks of large language models and prepare for AI that acts on its own. Talk Wed Oct 7 12:25 Talk Wed Oct 7 13:05 Roche approach to modernize shop floor operations with AI How Roche is replacing paper logs at its manufacturing sites with real-time digital records and a chat-based AI assistant for workers. Chair Wed Oct 7 15:25 Talk Wed Oct 7 15:30 Talk Wed Oct 7 15:30 AI, you, and the future of work What kinds of work AI will reshape and how employees and leaders can adopt it, with Klarna and Ikea as examples. Talk Wed Oct 7 15:30 Talk Wed Oct 7 15:50 Talk Wed Oct 7 15:50 Talk Wed Oct 7 16:30 Panel Wed Oct 7 17:25 Panel Wed Oct 7 17:25 Chair Thu Oct 8 11:05 Talk Thu Oct 8 11:10 Evaluating Data Utility in Anonymization, Federated Approaches, and OMOP-CDM Testing how much a breast cancer study's data stays useful after being anonymized, split across sites, or converted to a shared format. Talk Thu Oct 8 11:30 Talk Thu Oct 8 12:10 From Awareness to Adoption: Driving Change Beyond the Go-Live Why telling staff about a new system is not enough, and how to help them truly adopt it after launch. |
Servier Suresnes, France | |
French pharmaceutical group developing medicines, with a focus on oncology. | Panel Tue Oct 6 17:25 Talk Wed Oct 7 12:25 Talk Wed Oct 7 15:50 |
Sanofi Paris, France | |
French pharmaceutical company developing medicines and vaccines. | Panel Tue Oct 6 17:25 Gaining a competitive advantage in drug discovery through linked, multi-dimensional data at scale What it takes to build large, well-labeled genome and cell datasets for AI drug discovery, and to link different datasets together. Talk Wed Oct 7 09:50 AI at Scale: Charting the Future of Pharmaceutical Innovation How drug companies can move from one-off AI projects to company-wide use, including data systems, staff buy-in and ethical rules. AI & large language models Talk Wed Oct 7 12:25 |
UK health research programme recruiting up to 5 million adults, with over 2.8 million participants so far. | Booth Exhibiting at Booth 421 Talk Tue Oct 6 15:50 Chair Wed Oct 7 11:40 Chair Wed Oct 7 15:25 Chair Wed Oct 7 15:25 Keynote Thu Oct 8 13:20 |
Instantly find 20 buyers in AI for imaging
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse BioTechX Europe 2026 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction